NYSE : EVH
Evolent Health, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 4.25 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 480.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 486.16M |
| Enterprise Value | 1.34B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 113.06M |
| Shares Outstanding | 113.06M |
| Shares Change (YoY) | -2.39% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 1.95% |
| Owned by Institutions (%) | 82.66% |
| Float | 94.23M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 12.24 |
| PS Ratio | 0.23 |
| Forward PS | 0.16 |
| PB Ratio | 1.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.19 |
| P/OCF Ratio | 8.95 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.64 |
| EV / EBITDA | 21.97 |
| EV / EBIT | n/a |
| EV / FCF | 58.45 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.24 |
| Quick Ratio | 1.15 |
| Debt / Equity | 2.53 |
| Debt / EBITDA | 14.99 |
| Debt / FCF | 42.30 |
| Interest Coverage | -0.40 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -66.97% |
| Return on Assets (ROA) | -0.78% |
| Return on Invested Capital (ROIC) | -2.25% |
| Return on Capital Employed (ROCE) | -1.88% |
| Weighted Average Cost of Capital (WACC) | 7.05% |
| Revenue Per Employee | $499,290 |
| Profits Per Employee | -$121,680 |
| Employee Count | 4,200 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.85M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -39.27% |
| 50-Day Moving Average | 4.20 |
| 200-Day Moving Average | 3.87 |
| Relative Strength Index (RSI) | 49.16 |
| Average Volume (20 Days) | 1,810,867 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.90M |
| Short Previous Month | 14.07M |
| Short % of Shares Out | 10.53% |
| Short % of Float | 12.63% |
| Short Ratio (days to cover) | 5.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.10B |
| Gross Profit | 361.64M |
| Operating Income | -27.84M |
| Pretax Income | -502.14M |
| Net Income | -511.06M |
| EBITDA | 61.04M |
| EBIT | -27.84M |
| Loss Per Share | -$4.54 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 115.70M |
| Total Debt | 970.43M |
| Net Cash | -854.73M |
| Net Cash Per Share | -$7.56 |
| Equity (Book Value) | 383.22M |
| Book Value Per Share | 3.40 |
| Working Capital | 117.68M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 54.32M |
| Capital Expenditures | -31.37M |
| Depreciation & Amortization | 88.87M |
| Net Borrowing | -103.44M |
| Free Cash Flow | 22.94M |
| FCF Per Share | $0.20 |
Margins
| Measure | Value |
|---|
| Gross Margin | 17.25% |
| Operating Margin | -1.33% |
| Pretax Margin | -23.95% |
| Profit Margin | -24.08% |
| EBITDA Margin | 2.91% |
| EBIT Margin | -1.33% |
| FCF Margin | 1.09% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.39% |
| Shareholder Yield | 2.39% |
| Earnings Yield | -105.63% |
| FCF Yield | 4.72% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.75 |
| Price Target Difference | 33.72% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 25.01% |
| EPS Growth Forecast (3Y) | 82.67% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.36 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |